Short Interest in KORU Medical Systems, Inc. (NASDAQ:KRMD) Expands By 5.6%

KORU Medical Systems, Inc. (NASDAQ:KRMD) saw a significant growth in short interest in March. As of March 31st, there was short interest totalling 1,050,000 shares, a growth of 5.6% from the March 15th total of 994,500 shares. Based on an average trading volume of 95,500 shares, the days-to-cover ratio is presently 11.0 days.

KORU Medical Systems Price Performance

KRMD stock opened at $2.08 on Tuesday. The company has a debt-to-equity ratio of 0.02, a current ratio of 4.55 and a quick ratio of 3.77. The stock has a market capitalization of $95.08 million, a P/E ratio of -7.17 and a beta of 0.53. The business has a 50-day moving average of $2.19 and a 200-day moving average of $2.27. KORU Medical Systems has a fifty-two week low of $1.98 and a fifty-two week high of $4.48.

KORU Medical Systems (NASDAQ:KRMD) last posted its quarterly earnings data on Wednesday, March 13th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.02. KORU Medical Systems had a negative return on equity of 27.82% and a negative net margin of 48.18%. The company had revenue of $7.19 million during the quarter, compared to analysts’ expectations of $7.01 million. On average, sell-side analysts anticipate that KORU Medical Systems will post -0.15 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, B. Riley restated a “buy” rating and issued a $4.00 price target on shares of KORU Medical Systems in a report on Thursday, March 14th.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its position in KORU Medical Systems by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 1,909,874 shares of the company’s stock valued at $4,689,000 after purchasing an additional 21,286 shares during the last quarter. Meros Investment Management LP lifted its position in shares of KORU Medical Systems by 2.0% in the fourth quarter. Meros Investment Management LP now owns 525,764 shares of the company’s stock valued at $1,291,000 after buying an additional 10,368 shares during the last quarter. Barclays PLC acquired a new stake in shares of KORU Medical Systems in the fourth quarter valued at approximately $118,000. Nuveen Asset Management LLC boosted its stake in shares of KORU Medical Systems by 11.5% during the 4th quarter. Nuveen Asset Management LLC now owns 54,911 shares of the company’s stock worth $135,000 after acquiring an additional 5,649 shares during the period. Finally, Royal Bank of Canada boosted its stake in shares of KORU Medical Systems by 452.9% during the 4th quarter. Royal Bank of Canada now owns 43,205 shares of the company’s stock worth $105,000 after acquiring an additional 35,391 shares during the period. 58.60% of the stock is owned by institutional investors and hedge funds.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.